abstract |
SUMMARY OF THE INVENTION The present invention is directed to treating, preventing and reducing the risk of thromboembolic disorders, comprising administering a low molecular weight heparin such as tinzaparin and a platelet GPIIb / IIIa antagonist such as roxiban. For combination therapy. |